BioCorRx Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-1.1M | $2.6M |
| FY2020 | — | $-4.2M | $592.1K |
| FY2021 | $99.9K | $-7.0M | $85.8K |
| FY2022 | $0 | $-8.1M | $68.6K |
| FY2023 | — | $-9.8M | $65.2K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-1.1M | $2.6M |
| FY2020 | — | $-4.2M | $592.1K |
| FY2021 | $99.9K | $-7.0M | $85.8K |
| FY2022 | $0 | $-8.1M | $68.6K |
| FY2023 | — | $-9.8M | $65.2K |